Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Tuesday August 23 2016, @07:34AM   Printer-friendly
from the staying-alive-is-getting-more-expensive dept.

EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.

At Fortune, NYT, The Hill.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by HiThere on Tuesday August 23 2016, @03:09PM

    by HiThere (866) Subscriber Badge on Tuesday August 23 2016, @03:09PM (#392161) Journal

    I think a 5 year monopoly is generally justifiable. 10 years if there is a large amount of required initial investment...but you should need to really prove the requirement. And patents should be unenforceable against individuals whose income is less than half of yours...without allowing either party exemptions. Perhaps also companies should not be able to enforce patents against other companies whose income was less than half of theirs, but I'm less certain.

    --
    Javascript is what you use to allow unknown third parties to run software you have no idea about on your computer.
    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2